NTI-007

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameNTI-007
Drug Alias NameNTI-007
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/bile acid cotransporter inhibitors
TargetsSodium/bile acid cotransporter
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShenyang Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesShenyang Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A